Umb Bank, N.A. Ani Pharmaceuticals Inc Transaction History
Umb Bank, N.A.
- $5.92 Billion
- Q1 2025
A detailed history of Umb Bank, N.A. transactions in Ani Pharmaceuticals Inc stock. As of the latest transaction made, Umb Bank, N.A. holds 53 shares of ANIP stock, worth $3,750. This represents 0.0% of its overall portfolio holdings.
Number of Shares
53
Previous 33
60.61%
Holding current value
$3,750
Previous $1,000
200.0%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding ANIP
# of Institutions
218Shares Held
19.3MCall Options Held
3.4KPut Options Held
10.8K-
Black Rock Inc. New York, NY2.66MShares$188 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.31MShares$93 Million0.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny1MShares$71 Million0.03% of portfolio
-
State Street Corp Boston, MA737KShares$52.2 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY700KShares$49.5 Million0.01% of portfolio
About ANI PHARMACEUTICALS INC
- Ticker ANIP
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 17,426,000
- Market Cap $1.23B
- Description
- ANI Pharmaceuticals, Inc., a biopharmaceutical company, develops, manufactures, and markets branded and generic prescription pharmaceuticals in the United States and Canada. It focuses on producing controlled substances, oncology products, hormones and steroids, injectables, and other formulations. The company manufactures oral solid dose produc...